Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimerʼs disease
- 1 December 2002
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 13 (18) , 2429-2432
- https://doi.org/10.1097/00001756-200212200-00011
Abstract
Inhibition of protein translation is a mode of inducing neuronal apoptosis and neurodegeneration in Alzheimer's disease (AD). Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) terminates global protein translation and induces apoptosis. We examined whether this signaling pathway occurs in degenerating neurons of AD. Brain sections from young individuals, age-matched control individuals and AD patients were examined for immunoreactivity of phosphorylated eIF2alpha by immunohistochemical analysis. While young brain sections did not display and age-matched brain sections have mild immunoreactive positive cells, AD brain sections revealed intense immunoreactivity for phosphorylated eIF2alpha. Most of the phosphorylated eIF2alpha immunoreactive positive neurons have high immunoreactivity for phosphorylated tau using AT8 antibody. Also, intense staining of phosphorylated eIF2alpha is associated vacuoles in degenerating neurons. This phenomenon was also observed for the immunohistochemical staining of phosphorylated PKR (double-stranded RNA-dependent protein kinase), the upstream kinase for eIF2alpha. Activation of PKR-eIF2alpha pathway is considered to be pro-apoptotic. In addition, formation of autophagy is regulated by eIF2alpha kinase. Therefore, it is concluded that phosphorylation of eIF2alpha is associated with the degeneration of neurons in AD.Keywords
This publication has 21 references indexed in Scilit:
- Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degenerationJournal of Neurochemistry, 2002
- Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brainActa Neuropathologica, 2002
- Involvement of glycogen synthase kinase‐3β and tau phosphorylation in neuronal Golgi disassemblyJournal of Neurochemistry, 2002
- The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's diseaseActa Neuropathologica, 2002
- In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase‐3β in neuronal apoptosis: links to tau phosphorylationEuropean Journal of Neuroscience, 2002
- Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathologyPublished by Elsevier ,2001
- Activation of Caspase-3 in Single Neurons and Autophagic Granules of Granulovacuolar Degeneration in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- A New Molecular Link between the Fibrillar and Granulovacuolar Lesions of Alzheimer's DiseaseThe American Journal of Pathology, 1999
- In Situ Immunodetection of Neuronal Caspase-3 Activation in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 1999
- Molecular pathogenesis of sporadic and familial forms of Alzheimer's diseaseMolecular Medicine Today, 1998